{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:01:08Z","timestamp":1793138468903,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.blre.2024.101209","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T15:33:14Z","timestamp":1715095994000},"page":"101209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Cancer cytogenetics in a genomics world: Wedding the old with the new"],"prefix":"10.1016","volume":"66","author":[{"given":"Jorune","family":"Balciuniene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillard M.","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vania","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarina","family":"Sherpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.D.","family":"Morrissette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2024.101209_bb0005","first-page":"85","article-title":"Chromosome studies on normal and leukemic human leukocytes","volume":"25","author":"Nowell","year":"1960","journal-title":"J Natl Cancer Inst"},{"issue":"5405","key":"10.1016\/j.blre.2024.101209_bb0010","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.blre.2024.101209_bb0015","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/0092-8674(84)90438-0","article-title":"An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity","volume":"37","author":"Konopka","year":"1984","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.blre.2024.101209_bb0020","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.blre.2024.101209_bb0025","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials","volume":"116","author":"Grimwade","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.blre.2024.101209_bb0030","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.blre.2024.101209_bb0035","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa2024534","article-title":"Genome sequencing as an alternative to cytogenetic analysis in myeloid cancers","volume":"384","author":"Duncavage","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2024.101209_bb0040","series-title":"The AGT cytogenetics laboratory manual","author":"Arsham","year":"2017"},{"issue":"2","key":"10.1016\/j.blre.2024.101209_bb0045","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/pbc.23081","article-title":"Bone marrow aspiration technique may have an impact on therapy stratification in children with acute lymphoblastic leukaemia","volume":"57","author":"Helgestad","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.blre.2024.101209_bb0050","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cancergencyto.2010.07.128","article-title":"Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL research consortium (CRC) study","volume":"203","author":"Heerema","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"issue":"6","key":"10.1016\/j.blre.2024.101209_bb0055","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/gim.2016.50","article-title":"Section E6.1-6.4 of the ACMG technical standards and guidelines: chromosome studies of neoplastic blood and bone marrow-acquired chromosomal abnormalities","volume":"18","author":"Mikhail","year":"2016","journal-title":"Genet Med: Off J Am Coll Med Genet"},{"issue":"1","key":"10.1016\/j.blre.2024.101209_bb0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0165-4608(91)90058-3","article-title":"The proportion of abnormal karyotypes in acute leukemia samples related to method of preparation","volume":"52","author":"Li","year":"1991","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"10.1016\/j.blre.2024.101209_bb0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2141.1998.00951.x","article-title":"IL-4 improves the detection of cytogenetic abnormalities in multiple myeloma and increases the proportion of clonally abnormal metaphases","volume":"103","author":"Hern\u00e1ndez","year":"1998","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.blre.2024.101209_bb0070","first-page":"94","article-title":"Exclusion of chromosomal mosaicism: tables of 90%, 95% and 99% confidence limits and comments on use","volume":"29","author":"Hook","year":"1977","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.blre.2024.101209_bb0075","first-page":"239","article-title":"Central review of cytogenetics is necessary for cooperative group correlative and clinical studies of adult acute leukemia: the cancer and leukemia group B experience","volume":"33","author":"Mr\u00f3zek","year":"2008","journal-title":"Int J Oncol"},{"issue":"13","key":"10.1016\/j.blre.2024.101209_bb0080","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","article-title":"Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from cancer and leukemia group B (CALGB 8461)","volume":"100","author":"Byrd","year":"2002","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.blre.2024.101209_bb0085","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.blre.2024.101209_bb0090","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1182\/blood-2007-10-116186","article-title":"Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of southwest oncology group 9400 study","volume":"111","author":"Pullarkat","year":"2008","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.blre.2024.101209_bb0095","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1038\/s41375-020-0806-0","article-title":"Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia","volume":"34","author":"Herold","year":"2020","journal-title":"Leukemia"},{"issue":"25","key":"10.1016\/j.blre.2024.101209_bb0100","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1182\/blood-2009-08-231217","article-title":"T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII\/ECOG 2993)","volume":"114","author":"Marks","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.blre.2024.101209_bb0105","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood-2006-10-051912","article-title":"Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial","volume":"109","author":"Moorman","year":"2007","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.blre.2024.101209_bb0110","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.2020010144","article-title":"Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL","volume":"138","author":"Paietta","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.blre.2024.101209_bb0115","series-title":"An International System for Human Cytogenomic Nomenclature 2020","author":"McGowan-Jordan","year":"2020"},{"issue":"19","key":"10.1016\/j.blre.2024.101209_bb0120","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1182\/blood-2010-04-280313","article-title":"Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome","volume":"116","author":"G\u00f6hring","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.blre.2024.101209_bb0125","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41375-022-01561-w","article-title":"The complex karyotype in hematological malignancies: a comprehensive overview by the francophone group of hematological cytogenetics (GFCH)","volume":"36","author":"Nguyen-Khac","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.blre.2024.101209_bb0130","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1182\/blood-2018-09-873083","article-title":"Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact","volume":"133","author":"Baliakas","year":"2019","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.blre.2024.101209_bb0135","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.3324\/haematol.2021.279177","article-title":"Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials","volume":"107","author":"Creasey","year":"2022","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.blre.2024.101209_bb0140","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41375-019-0390-3","article-title":"Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinically","volume":"33","author":"Mr\u00f3zek","year":"2019","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.blre.2024.101209_bb0145","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1038\/s41467-022-32103-8","article-title":"Unified classification and risk-stratification in acute myeloid leukemia","volume":"13","author":"Tazi","year":"2022","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.blre.2024.101209_bb0150","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.blre.2024.101209_bb0155","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"5593","key":"10.1016\/j.blre.2024.101209_bb0160","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/265472a0","article-title":"High resolution detection of DNA-RNA hybrids in situ by indirect immunofluorescence","volume":"265","author":"Rudkin","year":"1977","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.blre.2024.101209_bb0165","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0037-1963(00)90013-1","article-title":"Fluorescence in situ hybridization: uses and limitations","volume":"37","author":"Gozzetti","year":"2000","journal-title":"Semin Hematol"},{"issue":"5","key":"10.1016\/j.blre.2024.101209_bb0170","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jmoldx.2020.02.004","article-title":"Design of a comprehensive fluorescence in situ hybridization assay for genetic classification of T-cell acute lymphoblastic leukemia","volume":"22","author":"La Starza","year":"2020","journal-title":"J Mol Diagn"},{"issue":"5","key":"10.1016\/j.blre.2024.101209_bb0175","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/bjh.17082","article-title":"Rapid fluorescence in situ hybridisation optimises induction therapy for acute myeloid leukaemia","volume":"191","author":"Nelson","year":"2020","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.blre.2024.101209_bb0180","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/gcc.21982","article-title":"High detection rate of clinically relevant genomic abnormalities in plasma cells enriched from patients with multiple myeloma","volume":"51","author":"Stevens-Kroef","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"issue":"7","key":"10.1016\/j.blre.2024.101209_bb0185","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1182\/bloodadvances.2022007583","article-title":"Optical genome mapping in acute myeloid leukemia: a multicenter evaluation","volume":"7","author":"Levy","year":"2023","journal-title":"Blood Adv"},{"issue":"8","key":"10.1016\/j.blre.2024.101209_bb0190","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ajhg.2021.06.001","article-title":"Next-generation cytogenetics: comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping","volume":"108","author":"Neveling","year":"2021","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.blre.2024.101209_bb0195","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrg.2016.49","article-title":"Coming of age: ten years of next-generation sequencing technologies","volume":"17","author":"Goodwin","year":"2016","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.blre.2024.101209_bb0200","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cell.2019.02.032","article-title":"Genomic analysis in the age of human genome sequencing","volume":"177","author":"Lappalainen","year":"2019","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.blre.2024.101209_bb0205","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood.2021014309","article-title":"Guiding the global evolution of cytogenetic testing for hematologic malignancies","volume":"139","author":"Akkari","year":"2022","journal-title":"Blood"},{"issue":"7834","key":"10.1016\/j.blre.2024.101209_bb0210","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41586-020-2864-x","article-title":"Single-cell mutation analysis of clonal evolution in myeloid malignancies","volume":"587","author":"Miles","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.blre.2024.101209_bb0215","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00281567","article-title":"The 11q;22q translocation: a European collaborative analysis of 43 cases","volume":"56","author":"Fraccaro","year":"1980","journal-title":"Hum Genet"},{"issue":"3","key":"10.1016\/j.blre.2024.101209_bb0220","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.annonc.2022.12.003","article-title":"Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO precision medicine working group recommendations","volume":"34","author":"Kuzbari","year":"2023","journal-title":"Ann Oncol: Off J Eur Soc Med Oncol"},{"issue":"1","key":"10.1016\/j.blre.2024.101209_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2024.101537","article-title":"Germline predisposition to myeloid neoplasms: characteristics and management of high versus variable penetrance disorders","volume":"37","author":"Trottier","year":"2024","journal-title":"Best Pract Res Clin Haematol"},{"issue":"21","key":"10.1016\/j.blre.2024.101209_bb0230","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood.2022015853","article-title":"Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia","volume":"140","author":"Duncavage","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.blre.2024.101209_bb0235","series-title":"GeneReviews\u00ae","article-title":"Fanconi anemia","author":"Mehta","year":"2002"},{"issue":"4","key":"10.1016\/j.blre.2024.101209_bb0240","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/jmedgenet-2019-106249","article-title":"Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies","volume":"57","author":"Bogliolo","year":"2020","journal-title":"J Med Genet"},{"key":"10.1016\/j.blre.2024.101209_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2022.100986","article-title":"Game of clones: diverse implications for clonal hematopoiesis in lymphoma and multiple myeloma","volume":"56","author":"Meier","year":"2022","journal-title":"Blood Rev"},{"issue":"8","key":"10.1016\/j.blre.2024.101209_bb0250","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/bloodadvances.2020004062","article-title":"Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged \u226580 years","volume":"5","author":"van Zeventer","year":"2021","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.blre.2024.101209_bb0255","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200310","article-title":"Prediction of risk for myeloid malignancy in clonal hematopoiesis","volume":"2","author":"Weeks","year":"2023","journal-title":"NEJM Evid"},{"issue":"6465","key":"10.1016\/j.blre.2024.101209_bb0260","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4673","article-title":"Clonal hematopoiesis in human aging and disease","volume":"366","author":"Jaiswal","year":"2019","journal-title":"Science (New York, NY)"},{"issue":"4","key":"10.1016\/j.blre.2024.101209_bb0265","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41409-024-02197-3","article-title":"Cytogenetic abnormalities predict survival after allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a PDWP\/EBMT study","volume":"59","author":"Sharma","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.blre.2024.101209_bb0270","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000507012","article-title":"Cytogenetics and blast count determine transplant outcomes in patients with active acute myeloid leukemia","volume":"144","author":"Olson","year":"2021","journal-title":"Acta Haematol"},{"issue":"1","key":"10.1016\/j.blre.2024.101209_bb0275","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4081\/oncol.2019.389","article-title":"Complex karyotype in myelodysplastic syndromes: diagnostic procedure and prognostic susceptibility","volume":"13","author":"Shahjahani","year":"2019","journal-title":"Oncol Rev"},{"issue":"1","key":"10.1016\/j.blre.2024.101209_bb0280","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2015.114","article-title":"Karyotype complexity and prognosis in acute myeloid leukemia","volume":"6","author":"St\u00f6lzel","year":"2016","journal-title":"Blood Cancer J"},{"issue":"26","key":"10.1016\/j.blre.2024.101209_bb0285","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1182\/blood-2011-08-373902","article-title":"Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML study IV","volume":"118","author":"Fabarius","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.blre.2024.101209_bb0290","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1002\/jcp.27505","article-title":"Chronic myeloid leukemia with complex karyotypes: prognosis and therapeutic approaches","volume":"234","author":"Asnafi","year":"2019","journal-title":"J Cell Physiol"},{"issue":"8","key":"10.1016\/j.blre.2024.101209_bb0295","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood-2006-10-051912","article-title":"Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial","volume":"109","author":"Moorman","year":"2007","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.blre.2024.101209_bb0300","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1038\/sj.leu.2404935","article-title":"Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping","volume":"21","author":"Haferlach","year":"2007","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.blre.2024.101209_bb0305","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000369543","article-title":"Detection of clonal aberrations by cytogenetic analysis after different culture methods and by FISH in 129 patients with chronic lymphocytic leukemia","volume":"144","author":"Jenderny","year":"2014","journal-title":"Cytogenet Genome Res"},{"issue":"7","key":"10.1016\/j.blre.2024.101209_bb0310","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41571-018-0018-y","article-title":"The multiple myelomas - current concepts in cytogenetic classification and therapy","volume":"15","author":"Kumar","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"10.1016\/j.blre.2024.101209_bb0315","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41375-019-0378-z","article-title":"European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms","volume":"33","author":"Rack","year":"2019","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.blre.2024.101209_bb0320","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1309\/AJCP7G4VMYZJQVFI","article-title":"Improved detection rate of cytogenetic abnormalities in chronic lymphocytic leukemia and other mature B-cell neoplasms with use of CpG-oligonucleotide DSP30 and interleukin 2 stimulation","volume":"139","author":"Shi","year":"2013","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.blre.2024.101209_bb0325","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2353\/jmoldx.2007.060128","article-title":"Guidance for fluorescence in situ hybridization testing in hematologic disorders","volume":"9","author":"Wolff","year":"2007","journal-title":"J Mol Diagn"},{"issue":"1","key":"10.1016\/j.blre.2024.101209_bb0330","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrc2764","article-title":"From pathogenesis to treatment of chronic lymphocytic leukaemia","volume":"10","author":"Zenz","year":"2010","journal-title":"Nat Rev Cancer"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X24000420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X24000420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T18:36:25Z","timestamp":1718390185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X24000420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":66,"alternative-id":["S0268960X24000420"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2024.101209","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer cytogenetics in a genomics world: Wedding the old with the new","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2024.101209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101209"}}